Dr. Anoop. P
Consultant in Hematology and Pediatric Hemato-Oncology
  

Quick Links

Dr. Anoop. P

MBBS, MD, DCH, FRCPCH, FRCPath, CCST

Professor & Consultant in Hematology and Pediatric Hemato-Oncology

+91 903 501 8115

This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Dr. Anoop is a Hematologist and Pediatric Hemato-Oncologist, providing tertiary referral services for malignant hematology (adults & children), non-malignant hematology (adults & children) and solid tumors (children). He is an active member of many professional bodies including Indian Academy of Pediatrics (IAP), British Society for Hematology (BSH), Royal College of Pediatrics& Child Health (RCPCH), Royal College of Pathologists (RCPath) and European Hematology Association (EHA). He has presented topics at recent scientific meetings on lymphoma (Lugano, Switzerland), leukemia (London, UK), stem cell mobilization (Baltimore, USA), autoimmune hemolytic anemia (Guildford, UK) and clinical trials (Oslo, Norway).

 

Experience

Dr. Anoop is a UK-trained Hematologist and Pediatric Hemato-Oncologist with clinical experience from globally reputed Hemato-Oncology centers in London including Royal Marsden Hospital, St George’s Hospital and Great Ormond Street Hospital. After completion of MBBS degree and MD in Pediatrics from Kerala, Dr. Anoop went abroad to pursue higher specialist training in Hemato-Oncology. He worked in the UK for 9 years, of which most of the time was spent in London. Additionally, he has also worked short stints at Warwickshire and Derbyshire. He has trained under and worked with many internationally renowned experts in Hematology and Oncology.

Specialty Interest

  • Blood disorders in adults and children.
  • Solid organ cancers in children.

Research & Publications

Dr. Anoop possesses a rich academic profile with over 50 publications in reputed international medical journals indexed by Medline/PubMed (the complete list of publications to date is available from:http://www.ncbi.nlm.nih.gov/pubmed?term=%22Anoop%20P%22%20%5BAuthor%5D). In addition, he is a reviewer for journals such as Hematology, Pediatric Hematology & Oncology, International Journal of Laboratory Hematology, Indian Pediatrics and Journal of Pediatric Hematology & Oncology. Some of hisrecent and frequently cited publications include:
  • Anoop P, Sankpal S, Stiller C, Tewari S, Lancaster DL, Khabra K, Taj MM. Outcome of childhood relapsed or refractory mature B-cell non-Hodgkin lymphoma and acute lymphoblastic leukemia. Leuk Lymphoma. 2012 Oct; 53(10): 1882-1888.
  • Anoop P. Immune thrombocytopenic purpura: historical perspective, current status, recent advances and future directions.Indian Pediatr. 2012 Oct; 49(10): 811-818.
  • Anoop P, Lancaster DL, Rassam SM, Atra A. Florid erythroid dysplasia mimicking congenital dyserythropoietic anemia during the preleukemic phase of acute erythroleukemia. Pediatr Hematol Oncol. 2012 Mar; 29(2): 173-175.
  • Anoop P, Shaw BE, Riley U, Ethell ME, Taj M, Lancaster DL, Atra A, Saso R, Littlewood S, Mohammed K, Davies F, Treleaven J, Morgan GJ, Potter MN. Clinical profile and outcome of urotheliotropic viral haemorrhagic cystitis following haematopoietic stem cell transplantation: a 7-year tertiary centre analysis. Hematology. 2011 Jul; 16(4): 213-220.
  • Anoop P, Lancaster DL, Atra A. Osteolytic presentation of pediatric acute megakaryoblasticleukemia.PediatrHematolOncol. 2011 Sep;28(6):526-528.
  • Islam MS, Anoop P, Datta-Nemdharry P, Sage D, Gordon-Smith EC, Turner D, Wiltshire S, O'Regan L, Marsh JC. Implications of CD34+ cell dose on clinical and haematological outcome of allo-SCT for acquired aplastic anaemia. Bone Marrow Transplant. 2010 May; 45(5): 886-894.
  • Addada J, Anoop P, Swansbury JG, Wotherspoon A, Thomas JM, Matutes E. Synchronous mantle cell lymphoma, chronic lymphocytic leukaemia and melanoma in a single lymph node. Acta Haematol. 2010 Mar; 123(3): 194-196.
  • Anoop P, Ravindranathan G, Osuji N, Dearden CE, Wotherspoon A, Bain BJ, Matutes E. Epstein-Barr virus negative large B-cell lymphoma during long term immunomodulatory therapy for T-cell large granular lymphocytic leukaemia. Br J Haematol. 2010 Jan; 148(2): 337-339.
  • Anoop P. Near total effacement of bone marrow by medulloblastoma. Am J Hematol. 2010 Feb; 85(2): 128.
  • Anoop P. Variations in the treatment threshold for immune thrombocytopenic purpura. Pediatr Blood Cancer. 2009 Mar; 52(3): 429.
  • Anoop P, Hargrave D, Zacharoulis S, Saran F. Diagnostic and therapeutic challenges owing to concurrent pontineglioma and acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2008 Jun; 30(6):454-457.
  • Anjay MA, Anoop P, Britland A. Leukocytosis as a predictor for progression to haemolytic uraemic syndrome in Escherichia coli O157:H7 infection. Arch Dis Child. 2007 Sep; 92(9): 820-823.